These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 24913320

  • 1. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
    Zhang Y, Li J, Song Y, Chen F, Pei Y, Yao F.
    Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
    [Abstract] [Full Text] [Related]

  • 2. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
    Shang D, Bi R, Han T, Wang D, Tian Y, Liu Y.
    Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
    Guan Y, Song H, Zhang G, Ai X.
    Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
    [Abstract] [Full Text] [Related]

  • 4. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY, Yao AM, Chang XN, Guo YH, Xu R.
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [Abstract] [Full Text] [Related]

  • 5. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL, Kang K, Yoon S, Huang SM, Lim JS, Kim JM, Lim JS, Lee HJ.
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
    Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L.
    Mol Cancer; 2014 May 17; 13():109. PubMed ID: 24886554
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J, Li W, Liu H, Yan L, Jiao W, Li D, Tang Y, Gu G, Xu Z.
    Urol Oncol; 2013 Oct 17; 31(7):1358-66. PubMed ID: 22341977
    [Abstract] [Full Text] [Related]

  • 8. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
    Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J, Song L.
    Clin Cancer Res; 2011 May 15; 17(10):3089-99. PubMed ID: 21447726
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ, Su XL, Cheng WL, Zhang HJ, Zhao YQ, Han ZX.
    Urol Oncol; 2014 Feb 15; 32(2):153-61. PubMed ID: 23273913
    [Abstract] [Full Text] [Related]

  • 10. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 11. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.
    Eur Urol; 2009 Mar 15; 55(3):669-78. PubMed ID: 18450365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A, Nagase H, Obinata D, Fujiwara K, Fukuda N, Soma M, Yamaguchi K, Kawata N, Takahashi S.
    Int J Oncol; 2013 Nov 15; 43(5):1441-6. PubMed ID: 23969530
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
    Papworth K, Bergh A, Grankvist K, Ljungberg B, Sandlund J, Rasmuson T.
    Acta Oncol; 2013 Jan 15; 52(1):159-65. PubMed ID: 22731830
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.